Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous rhTNK-tPA Bridging With Endovascular Treatment Versus Endovascular Treatment Alone For Stroke Patient With Large Vessel Occlusion: A Multicenter, Randomized Controlled Trial

NCT04733742 is registered in ClinicalTrials.gov with Xinqiao Hospital of Chongqing as lead sponsor.

NCT NCT04733742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04733742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous rhTNK-tPA Bridging With Endovascular Treatment Versus Endovascular Treatment Alone For Stroke Patient With Large Vessel Occlusion: A Multicenter, Randomized Controlled Trial
Lead sponsor
Xinqiao Hospital of Chongqing
Phase
Phase 2/3
Overall status
Completed
Start date
May 9, 2022
Completion date
February 7, 2025
Enrollment
550 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, acute, stroke, ischemic